Carl Byrnes
Stock Analyst at Northland Capital Markets
(2.51)
# 2,290
Out of 5,129 analysts
26
Total ratings
52.63%
Success rate
13.93%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BWAY BrainsWay | Maintains: Outperform | $19 → $23 | $23.43 | -1.84% | 5 | Nov 12, 2025 | |
| SNWV SANUWAVE Health | Initiates: Outperform | $55 | $24.70 | +122.67% | 1 | Sep 3, 2025 | |
| BLFS BioLife Solutions | Maintains: Outperform | $28 → $31 | $22.25 | +39.33% | 2 | Jan 8, 2025 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $13 | $4.80 | +160.42% | 1 | Oct 25, 2024 | |
| MDAI Spectral AI | Initiates: Outperform | $6 | $1.54 | +289.61% | 1 | Aug 12, 2024 | |
| COCH Envoy Medical | Initiates: Outperform | n/a | $0.66 | - | 1 | Dec 21, 2023 | |
| AMRN Amarin Corporation | Maintains: Market Perform | $40 → $25 | $15.11 | +65.45% | 1 | Jul 19, 2023 | |
| CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $240 | $1.32 | +18,081.82% | 1 | May 22, 2023 | |
| VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $34.46 | +132.15% | 4 | Aug 17, 2022 | |
| MDXG MiMedx Group | Initiates: Outperform | $23 | $5.21 | +341.46% | 3 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $30 → $24 | $3.46 | +593.64% | 4 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2,000 | $2.27 | +88,005.73% | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.17 | - | 1 | Sep 27, 2017 |
BrainsWay
Nov 12, 2025
Maintains: Outperform
Price Target: $19 → $23
Current: $23.43
Upside: -1.84%
SANUWAVE Health
Sep 3, 2025
Initiates: Outperform
Price Target: $55
Current: $24.70
Upside: +122.67%
BioLife Solutions
Jan 8, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $22.25
Upside: +39.33%
TriSalus Life Sciences
Oct 25, 2024
Initiates: Outperform
Price Target: $13
Current: $4.80
Upside: +160.42%
Spectral AI
Aug 12, 2024
Initiates: Outperform
Price Target: $6
Current: $1.54
Upside: +289.61%
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $0.66
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $40 → $25
Current: $15.11
Upside: +65.45%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $240
Current: $1.32
Upside: +18,081.82%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $34.46
Upside: +132.15%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: $23
Current: $5.21
Upside: +341.46%
May 5, 2021
Maintains: Market Perform
Price Target: $30 → $24
Current: $3.46
Upside: +593.64%
Oct 22, 2018
Initiates: Outperform
Price Target: $2,000
Current: $2.27
Upside: +88,005.73%
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $1.17
Upside: -